Navigating Treatment Challenges: A Case Study on Refractory Psychosis in a Chronic MDMA (3,4-Methylenedioxymethamphetamine) User.
Melissa N Litenski, Aoife B O'Reardon, Nicole Pabon, Melissa Hernandez, Yakov Niyazov, Jose Cruz
Cureus May 1, 2024 DOI: 10.7759/cureus.59641 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | 23-year-old woman with chronic MDMA use disorder and childhood trauma |
| Intervention | Electroconvulsive therapy |
| Topics | MDMA |
| Keywords | Alternative treatments Antipsychotics Bipolar i disorder Drug addiction Drug-induced catatonia Electroconvulsive therapy ect MDMA Use Psychosis refractory psychosis Drug-induced psychosis Treatment-resistant psychosis Electroshock therapy MDMA Ecstasy Drug abuse |
| Citations | 1 |
| Key findings | Conventional antipsychotics failed to improve psychotic symptoms and worsened catatonia, but electroconvulsive therapy (ECT) led to improvement in a patient with bipolar I disorder exacerbated by MDMA use. |
Abstract
MDMA (3,4-methylenedioxymethamphetamine), also known as Ecstasy, is a synthetic amphetamine with hallucinogenic and stimulant properties, which has become increasingly favored as a substance for recreational use. Despite its deceptive reputation as "safe," chronic MDMA use is associated with neuropsychiatric complications, including psychosis. We describe a case of a 23-year-old woman with chronic MDMA use disorder and childhood trauma, who presented with severe psychosis and catatonic features. While initial diagnostic possibilities included drug-induced psychosis and mood disorders, the patient's history and presentation supported a diagnosis of bipolar I disorder with psychotic features, which was exacerbated by MDMA use. Conventional antipsychotics failed to improve psychotic symptoms and led to worsening of catatonia, requiring electroconvulsive therapy (ECT) for improvement. Socioeconomic barriers hindered follow-up care, leading to an Emergency Department (ED) admission shortly after discharge. This case highlights the intricate interplay between substance use, psychiatric illness, and trauma, and showcases ECT's efficacy in severe psychosis. It emphasizes the necessity for comprehensive mental health services, especially for vulnerable populations, and calls for further research into MDMA's psychiatric effects and optimal treatment approaches for individuals with co-occurring substance use and psychiatric disorders.